SCHEDULE 13D/A: Prescott Group Enters Standstill Agreement with Performant Healthcare, Maintains 20.2% Stake

Prescott Group Capital Management, a significant shareholder in Performant Healthcare, Inc., has entered into a confidentiality and standstill agreement with the company, limiting its activist actions for 12 months while it evaluates the business.

Summary

• Prescott Group Capital Management, L.L.C. and its affiliated funds (Prescott Group Aggressive Small Cap, L.P., Prescott Group Aggressive Small Cap II, L.P., and Prescott Group Aggressive Small Cap Master Fund, G.P.), along with Phil Frohlich, collectively beneficially own 15,793,291 shares of Performant Healthcare, Inc. Common Stock.
• This ownership represents approximately 20.2% of the Issuer's outstanding Common Stock, based on 78,308,640 shares outstanding as of May 8, 2025.
• As of June 9, 2025, the Master Fund had invested $25,494,418.84 (inclusive of brokerage commissions) in the Issuer's Common Stock, funded by its working capital.
• On June 5, 2025, Prescott Capital entered into a Confidentiality Agreement with Performant Healthcare, Inc., dated June 4, 2025.
• The agreement grants Prescott Capital access to certain information to evaluate the Issuer's current and proposed business operations.
• The Confidentiality Agreement includes a 12-month 'standstill' provision, effective from June 4, 2025, which restricts Prescott Capital and its affiliates from various actions, including acquiring more voting securities, soliciting proxies, forming a group, proposing mergers, or seeking to influence management or the Board, unless invited by the Board.
• The standstill obligations terminate if the Issuer enters into a definitive agreement to be acquired (majority voting securities or assets) or publicly announces such an intention.
• The Confidentiality Agreement can be terminated by either party with written notice, but rights, restrictions, and obligations remain in effect for six months following termination notice.
• The Reporting Persons intend to continuously review their investment and may take future actions, including acquiring or disposing of securities or engaging in hedging, subject to the Confidentiality Agreement's limitations.
• There have been no transactions by the Reporting Persons in the Issuer's securities within the past 60 days.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While the standstill limits the investor's immediate actions, it suggests a constructive engagement between a major shareholder and the company, potentially leading to more informed decisions and stability. The company benefits from a period free from activist pressure from this specific investor.

Positives

• The standstill agreement provides a period of stability for Performant Healthcare, Inc., by limiting potential activist actions from a significant shareholder for 12 months.
• Prescott Group Capital Management gains access to confidential information, allowing for a more informed evaluation of Performant Healthcare's business operations.

Negatives

• The standstill agreement restricts Prescott Group Capital Management's ability to acquire additional shares, engage in proxy solicitations, or propose significant corporate actions for a 12-month period, limiting its immediate flexibility as an activist investor.

Risks

• The document does not explicitly list general business risks for Performant Healthcare, Inc. It primarily details the terms of a confidentiality and standstill agreement between the company and a major shareholder.

Future Outlook

The Reporting Persons intend to continuously review their investment in Performant Healthcare, Inc. and may, depending on various factors such as the Issuer's financial position, strategic direction, Board actions, and market conditions, acquire or dispose of additional securities, engage in hedging transactions, or propose other actions, all subject to the limitations imposed by the Confidentiality Agreement.

Management Comments

• Simeon Kohl, CEO of Performant Healthcare, Inc., signed the Confidentiality Agreement on behalf of the Company.
• Phil Frohlich, Managing Member of Prescott Group Capital Management, LLC, signed the Confidentiality Agreement on behalf of the Investor.

Industry Context

This filing primarily details a specific shareholder's investment position and a confidentiality/standstill agreement, rather than broader industry trends. It reflects a common practice where significant investors seek more information about a company while agreeing to temporary limitations on activist behaviors.

Corporate Governance

Stakeholder Impact

• Shareholders: The standstill agreement may provide a period of stability, potentially reducing volatility associated with activist investor actions. It also indicates a structured engagement between a major shareholder and the company.
• Management/Board: The agreement grants the current management and Board a 12-month period free from certain activist pressures from Prescott Group, allowing them to focus on business operations and strategic plans.

Next Steps

• Prescott Group Capital Management will continue to review its investment in Performant Healthcare, Inc. on an ongoing basis.
• Prescott Group Capital Management may acquire or dispose of additional securities, engage in hedging, or propose other actions in the future, subject to the terms of the Confidentiality Agreement.

Key Dates

Keywords

Performant Healthcare Inc., Prescott Group Capital Management, Schedule 13D, Confidentiality Agreement, Standstill Agreement, Shareholder Activism, Beneficial Ownership, Common Stock, SEC Filing, Investment Management